✦ LIBER ✦

A Controlled, Evidence-Based Trial of Paliperidone Palmitate, A Long-Acting Injectable Antipsychotic, in Schizophrenia

✍ Scribed by Yuen, Eric; Hough, David; Nasrallah, Henry A; Gopal, Srihari; Gassmann-Mayer, Cristiana; Quiroz, Jorge A; Lim, Pilar; Eerdekens, Mariëlle

Book ID: 111945322
Publisher: Nature Publishing Group
Year: 2010
Tongue: English
Weight: 498 KB
Volume: 35
Category: Article
ISSN: 1470-634X
DOI: 10.1038/npp.2010.79

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comparative study of paliperidone palm

A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia

✍ Huafang Li; Qing Rui; Xiaoping Ning; Haiyan Xu; Niufan Gu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 374 KB

A double-blind study of paliperidone pal

A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia

✍ Gahan Pandina; Rosanne Lane; Srihari Gopal; Cristiana Gassmann-Mayer; David Houg 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 543 KB

PMH42 Cost-Utility Analysis of Paliperid

PMH42 Cost-Utility Analysis of Paliperidone Palmitate Long Acting Injection(PLAI) Versus Oral Atypical Antipsychotics in Non-Adherent Schizophrenia Patients

✍ B.R.M. Kim; T.J. Lee; J.M. Woo; J.I. Park; J.S. Kwon 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

P.3.c.041 A randomized, double-blind stu

P.3.c.041 A randomized, double-blind study of paliperidone palmitate and risperidone long-acting therapy in schizophrenia

✍ G. Pandina; R. Lane; S. Gopal; C. Gassmann-Mayer; D. Hough; B. Remmerie; G. Simp 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 60 KB

PMH23 A Cost-Effectiveness Analysis of t

PMH23 A Cost-Effectiveness Analysis of the Long-Acting Antispychotic Drugs Paliperidone Palmitate, Olanzapine Pamoate and Risperidone in the Treatment of Schizophrenia in Finland

✍ T.R. Einarson; H. Pudas; R. Zilbershtein; R. Jensen; A.T. Nielsen; C. Piwko; M. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

More evidence on additive antipsychotic

More evidence on additive antipsychotic effect of adjunctive mirtazapine in schizophrenia: an extension phase of a randomized controlled trial

✍ Viacheslav Terevnikov; Jan-Henry Stenberg; Marina Joffe; Jari Tiihonen; Mark Bur 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

## Abstract ## Objective Adjunctive mirtazapine improved negative symptoms of schizophrenia in several studies. Recently, we found an improvement also in positive symptoms when mirtazapine was added to first generation antipsychotics (FGAs) in a 6 week randomized controlled trial (RCT). The short